Literature DB >> 16865210

Cardiac disease in beta-thalassaemia major: Is it reversible?

M Atiq1, M Bana, U S Ahmed, S Bano, M Yousuf, Z Fadoo, M Khurshid.   

Abstract

INTRODUCTION: The aim of this study was to evaluate the spectrum of cardiac involvement and its outcome in beta-thalassaemia major.
METHODS: There were 75 patients with a mean age of 13.8 (+/- 5.5) years, of whom 33 were male and 42 were female. Clinical history, examination and laboratory investigations were assessed. Electrocardiograms, chest radiographs and echocardiograms were reviewed.
RESULTS: 44 patients had cardiac involvement in the form of left ventricular systolic dysfunction in 17, diastolic dysfunction in 22, pericardial effusion in 12 and pulmonary hypertension in 12 patients. With intense chelation therapy and cardiac medications, the condition of 13 of 17 patients with systolic dysfunction, and four of 22 with diastolic dysfunction, improved.
CONCLUSION: Cardiac disease is a common complication of siderotic disease in thalassaemia major and it can be prevented with regular chelation. This study has shown improved systolic function after regular chelation therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865210

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  5 in total

1.  The effect of metoprolol succinate on the cardiac function of patients with thalassaemia cardiomyopathy: a double-blind randomised study.

Authors:  Javad Kojury; Abdolali Zolghadrasli; Mehran Karimi; Mohammad Ali Babaee Beighi; Soha Namazi
Journal:  Heart Asia       Date:  2014-04-17

2.  A Comparison Between MRIT2 and NT-ProBNP in Early Detection of Heart Diseases in Thalassemia Major Patients: A Cross-Sectional Study.

Authors:  Kourosh Goudarzipour; Parinaz Alizadeh; Hesameddin Hoseini Tavassol; Reyhaneh Kazemi; Peyman Eshghi; Saeed Mojtahedzadeh
Journal:  Indian J Hematol Blood Transfus       Date:  2017-02-27       Impact factor: 0.900

3.  Association between serum ferritin level and diastolic cardiac function in patients with major β-thalassemia.

Authors:  A Eghbali; H Taherahmadi; B Bagheri; S Nikanjam; L Ebrahimi
Journal:  Iran J Ped Hematol Oncol       Date:  2015-04-20

4.  The Correlation between Troponin and Ferritin Serum Levels in the Patients with Major Beta-Thalassemia.

Authors:  Iraj Shahramian; Motahhare Razzaghian; Abbas Ali Ramazani; Ghasem Ali Ahmadi; Noor Mohammad Noori; Ali Reza Rezaee
Journal:  Int Cardiovasc Res J       Date:  2013-06-01

5.  Cost-Utility Analysis of four Chelation Regimens for β-thalassemia Major: a Chinese Perspective.

Authors:  Jialian Li; Peng Wang; Xue Li; Qiaoyu Wang; Jiayou Zhang; Yong Lin
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-05-01       Impact factor: 2.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.